featured-image

Loading...

Loading...



Vaccine stocks have been on the fly ever since a never-before-seen bird flu strain started infecting people around the globe . On Thursday, a 59-year-old man with previous health conditions died in Mexico after contracting the H5N2 virus. The source of the virus in this case remains unknown.

The Mexican strain is different from H5N1, which has undergone extensive genetic diversification since 2005. Bird flu, also known as avian influenza, is a type of disease caused by the influenza A virus. It primarily affects birds but can also be contracted by mammals like cats, cows and humans.

See Also: Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment Stocks To Watch Moderna Inc MRNA shares were up 1.3% on Thursday and almost 29% this month. CureVac BV CVAC , a German biotech firm, is up 12% this week and 72% in the past month as countries like the U.

S and Australia seek to accumulate more vaccines. Novavax Inc NVAX has spiked a whopping 317% in the past month, losing 5.5% on Thursday at the time of this writing.

‘Fairly Extreme’ Analysts quoted by Bloomberg have read recent spikes in vaccine stocks as "fairly extreme." The volatility in stock prices can be attributed to speculation around retail trading based on headlines rather than to actual expectations for the companies' profit potential. Among the recent headlines are the U.

S. government’s nearing an agreement to financially support a late-stage trial for an mRNA bird flu vac.

Back to Health Page